• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Renexxion And Dr. Falk Expand Naronapride Study, Dose First US Patient

    GLOBENEWSWIRE

    Renexxion Announce FDA Clearance of the Naronapride to Treat Gastroparesis

    GLOBENEWSWIRE

    Renexxion Partner, Dr. Falk Pharma GmbH, has Elected PPI-non-responsive Symptomatic GERD as the Second Naronapride Indication to Develop and Commercialize in their Licensed Territories

    GLOBENEWSWIRE

    Renexxion to Present at the Oppenheimer 34áµ—Ê° Annual Healthcare Conference

    GLOBENEWSWIRE

    Renexxion Ireland Announces FDA Clearance of IND)Application for Naronapride

    GLOBENEWSWIRE

    Renexxion has Completed Consultation with FDA for Development of Naronapride

    GLOBENEWSWIRE

    Renexxion Announces Issuance of Two U.S. Patents Covering Naronapride

    GLOBENEWSWIRE

    Renexxion to Present at the Oppenheimer Healthcare Private Company Showcase

    GLOBENEWSWIRE

    Renexxion Ireland begins Phase IIb trial of gastroparesis therapy

    CLINICAL TRIALS ARENA

    Renexxion reveals plans to address GI symptoms in cystic fibrosis patients

    CLINICAL TRIALS ARENA

    Renexxion Announces Opening of IND Application for Naronapride

    PR NEWSWIRE

    Renexxion Ireland Announces Issuance of New US Patent covering Naronapride

    PRNEWSWIRE

    Renexxion Ireland Announces Issuance of New US Patent covering Naronapride

    PRNEWSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.